These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2117801)

  • 1. The treatment of steroid-resistant renal allograft rejection with OKT3 and plasmapheresis.
    Haberal M; Sert S; Gülay H; Arslan G; Bilgin N
    Transplant Proc; 1990 Aug; 22(4):1761-3. PubMed ID: 2117801
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment with OKT3 and cyclosporine for acute allograft rejection.
    Schulak JA; Mayes JT; Hricik DE
    Transplant Proc; 1991 Aug; 23(4):2119-22. PubMed ID: 1908150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histologic findings and kidney graft outcome in patients with steroid-resistant rejections before and after OKT3 therapy.
    Niebel W; Metz KA; Albrecht KH; Wagner K; Kribben A; Erhard J; Eigler FW
    Transplant Proc; 1990 Aug; 22(4):1764. PubMed ID: 2117802
    [No Abstract]   [Full Text] [Related]  

  • 4. Rescue of severe steroid-resistant rejection with OKT3.PAN.
    Ponticelli C; Rivolta E; Tarantino A; De Vecchi A; Vegeto A
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1908-9. PubMed ID: 3274449
    [No Abstract]   [Full Text] [Related]  

  • 5. Preliminary results of a prospectively randomized trial of ALG vs OKT3 for steroid-resistant rejection after renal transplantation in the early postoperative period.
    Hesse UJ; Wienand P; Baldamus C; Arns W
    Transplant Proc; 1990 Oct; 22(5):2273-4. PubMed ID: 2120814
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term efficacy of OKT3 for steroid-resistant acute rejection in renal transplant patients.
    Kumano K; Irie A; Mashimo S; Endo T; Koshiba K
    Transplant Proc; 1996 Jun; 28(3):1354-5. PubMed ID: 8658691
    [No Abstract]   [Full Text] [Related]  

  • 7. Reversal of steroid- and antithymocyte globulin-resistant acute rejection crises in renal transplantation with monoclonal antibody (OKT3).
    Prieto C; Rodriguez-Paternina E; Andrés A; Morales JM; Farias J; Montoyo C; Regueiro JR; Rodicio JL
    Transplant Proc; 1990 Aug; 22(4):1753-4. PubMed ID: 2117798
    [No Abstract]   [Full Text] [Related]  

  • 8. Orthoclone OKT3 treatment of acute renal allograft rejection in patients receiving maintenance cyclosporine therapy.
    Hirsch RL; Layton PC; Barnes LA; Kremer AB; Goldstein G
    Transplant Proc; 1987 Apr; 19(2 Suppl 1):32-6. PubMed ID: 3105138
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of Orthoclone OKT3 monoclonal antibody to reverse acute renal allograft rejection unresponsive to treatment with conventional immunosuppressive regimens.
    Monaco A; Goldstein G; Barnes L
    Transplant Proc; 1987 Apr; 19(2 Suppl 1):28-31. PubMed ID: 3105137
    [No Abstract]   [Full Text] [Related]  

  • 10. Uses of orthoclone OKT3 for prophylaxis of rejection and induction in initial nonfunction in kidney transplantation.
    Kahana L; Ackermann J; Lefor W; Weinstein S; Wright C; DeQuesada A; Alveranga D; Baxter J; Shires D
    Transplant Proc; 1990 Aug; 22(4):1755-8. PubMed ID: 2117799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OKT3 treatment of steroid- and/or anti-thymocyte globulin-resistant renal allograft rejection occurring on triple baseline immunosuppression including cyclosporine A.
    Widmer U; Frei D; Keusch G; Burger HR; Largiader F; Binswanger U
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):90-5. PubMed ID: 3140454
    [No Abstract]   [Full Text] [Related]  

  • 12. Orthoclone OKT3 as rescue treatment for steroid-resistant and recurrent acute rejection in clinical renal transplantation.
    Tvedegaard E; Olgaard K
    Transplant Proc; 1990 Feb; 22(1):217-8. PubMed ID: 2106738
    [No Abstract]   [Full Text] [Related]  

  • 13. OKT3 therapy in addition to tacrolimus is associated with improved long-term function in patients with steroid refractory renal allograft rejection.
    Patschan D; Kribben A; Pietruck F; Lutz J; Binek M; Philipp T; Heemann U; Witzke O
    Nephron Clin Pract; 2006; 103(3):c94-9. PubMed ID: 16534238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective induction immunosuppression for cadaver renal transplantation at the St. Francis Regional Medical Center.
    Shield CF
    Clin Transpl; 1990; ():265-74. PubMed ID: 2129408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of induction ALG (MALG) on the outcome of steroid-resistant rejection treated with OKT3 in renal transplant patients.
    Chiu A; Landsberg D; Cameron EC; Manson AD; Shackleton C
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1039-40. PubMed ID: 1899146
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and renal histologic predictors of long-term outcome after OKT3 therapy for steroid-resistant rejection.
    Wiener Y; Nakhleh RE; Kupin WL; Lee M; Escobar FS; Venkat KK; Mozes MF
    Transplant Proc; 1995 Feb; 27(1):1014-5. PubMed ID: 7878781
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and patient satisfaction with outpatient-administered OKT3 in combined kidney/pancreaticoduodenal allograft recipients.
    Overman JA; Perkins JD
    Transplant Proc; 1990 Apr; 22(2):681-2. PubMed ID: 2109389
    [No Abstract]   [Full Text] [Related]  

  • 18. Orthoclone OKT3 as first-line therapy in acute renal allograft rejection.
    Strate M; Jørgensen KA; Rohr N; Elbirk A; Svendsen V; Birkeland SA
    Transplant Proc; 1990 Feb; 22(1):219-20. PubMed ID: 2106739
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal transplantation with cyclosporine in the elderly population.
    Velez RL; Brinker KR; Vergne-Marini PJ; Nesser DA; Long DL; Trevino G; Dickerman RM; Helfrich GB
    Transplant Proc; 1991 Apr; 23(2):1749-52. PubMed ID: 1905073
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of OKT-3 in treatment of rejection following kidney transplantation].
    Hansen C; Müller P; Seibt F; Oesterwitz H; May G; Strobelt V; Kaden J; Ditscherlein G; Scholz D
    Z Urol Nephrol; 1990 Apr; 83(4):165-70. PubMed ID: 2116055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.